___

• Kwo EC, Kamat P, Steinman MA. Physician use of brand versus generic drug names in 1993-1994 and 2003-2004. Ann Pharmacother 2009;43:459-68.
• IMS Institute for Healthcare Informatics. The role of generic medicines in sustaining healthcare systems: A European perspective 2015. Available from: URL: http://www.apmgr.org/docs/IIHI_Generics_Healthcare_Brief.pdf (Erişim tarihi: 25 Ocak 2019).
• Sacks CA, Lee CC, Kesselheim AS, Avorn J. Medicare spending on brand-name combination medications vs their generic constituents. JAMA 2018;320:650-6.
• Wouters OJ, Kanavos PG, McKEE M. Comparing generic drug markets in Europe and the United States: prices, volumes, and spending. Milbank Q 2017;95:554-601.
• Warraich HJ, Salami JA, Khera R, Valero-Elizondo J, Okunrintemi V, Nasir K. Trends in use and expenditures of brand-name atorvastatin after introduction of generic atorvastatin. JAMA Intern Med 2018;178:719-21.
• Kjoenniksen I, Lindbaek M, Granas AG. Patients' attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci 2006;28:284-9.
• Straka RJ, Keohane DJ, Liu LZ. Potential clinical and economic impact of switching branded medications to generics. Am J Ther 2017;24:e278-e289.
• Colgan S, Faasse K, Martin LR, Stephens MH, Grey A, Petrie KJ. Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review. BMJ Open 2015;5:e008915.
• Domeyer PJ, Aletras V, Anagnostopoulos F, Katsari V, Niakas D. Development and validation of a tool to assess knowledge and attitudes towards generic medicines among students in Greece: The ATtitude Towards GENerics (ATTOGEN) questionnaire. PLoS One 2017;12:e0188484.
• Dunne SS, Shannon B, Cullen W, Dunne CP. Beliefs, perceptions and behaviours of GPs towards generic medicines. Fam Pract 2014;31:467-74.
• Fabiano V, Mameli C, Cattaneo D, et al. Perceptions and patterns of use of generic drugs among Italian Family Pediatricians: First round results of a web survey. Health Policy 2012;104:247-52.
• Flood D, Mathieu I, Chary A, Garcia P, Rohloff P. Perceptions and utilization of generic medicines in Guatemala: a mixed-methods study with physicians and pharmacy staff. BMC Health Serv Res 2017;17:27.
• Lewek P, Smigielski J, Kardas P. Factors affecting the opinions of family physicians regarding generic drugs - a questionnaire based study. Bosn J Basic Med Sci 2015;15:45-50.
• Riner B, Bussy A, Hélène-Pelage J, Moueza N, Lamy S, Carrère P. “No generics, Doctor!” The perspective of general practitioners in two French regions. BMC Health Serv Res 2017;17:707.
• Banahan BF, Kolassa EM. A physician survey on generic drugs and substitution of critical dose medications. Arch Intern Med 1997;157:2080-8.
• Howard JN, Harris I, Frank G, Kiptanui Z, Qian J, Hansen R. Influencers of generic drug utilization: A systematic review. Res Social Adm Pharm 2018;14:619-27.
• Liou WS, Hsieh SC, Chang WY, Wu GHM, Huang HS, Lee C. Brand name or generic? What are the health professionals prescribed for treating diabetes? A longitudinal analysis of the National Health Insurance reimbursement database. Pharmacoepidemiol Drug Saf 2013;22:752-9.
• Shrank WH, Liberman JN, Fischer MA, Girdish C, Brennan TA, Choudhry NK. Physician perceptions about generic drugs. Ann Pharmacother 2011;45:31-8.
• Mondelo-García C, Mendoza E, Movilla-Fernández MJ, Coronado C. Perceptions of pharmacists and physicians on generic substitution in a financial crisis context in Northwestern Spain: A qualitative study. Health Policy 2018;122:1316-25.
• Hassali MA, Wong ZY, Alrasheedy AA, Salem F, Yahaya AHM, Aljadhey H. Perspectives of physicians practicing in low and middle income countries towards generic medicines: A narrative review. Health Policy 2014;117:297-310.
• https://www.istanbuleczaciodasi.org.tr/upload/pdf/20090618_es_deger_ilac.pdf (Erişim tarihi: 25 Ocak 2019).
• Toklu HZ, Dülger GA, Hıdıroğlu S, et al. Knowledge and attitudes of the pharmacists, prescribers and patients towards generic drug use in Istanbul - Turkey. Pharm Pract (Granada) 2012;10:199-206.
• Bilginer E, Ozçelikay G. A survey to evaluate the opinions of Turkish Physicians’ on bioequivalence. Turkish Journal of Pharmaceutical Sciences 2007;4:79-87.
• Dosedel M, Maly J, Kubena A, Vicek J. Opinions of Czech general practitioners on generic drugs and substitution. Cent Eur J Med 2014;9:830-8.
• Jamshed SQ, Ibrahim MIM, Hassali MA, et al. Perception and attitude of general practitioners regarding generic medicines in Karachi, Pakistan: A questionnaire based study. South Med Rev 2012;5;1:22-30.
• Türkiye İlaç ve Tıbbi Cihaz Kurumu. Beşeri Tıbbi Ürünler İmalathaneleri İyi İmalat Uygulamaları (GMP) Kılavuzu. Erişim: URL: http://www.titck.gov.tr/PortalAdmin/Uploads/UnitPages/%C4%B0%C4%B0U%20KILAVUZU%20V.2017-01.pdf (Erişim tarihi: 02 Ekim 2019).
• Türkiye İlaç ve Tıbbi Cihaz Kurumu. Farmasötik Müstahzarların Biyoyararlanım ve Biyoeşdeğerliliğinin Değerlendirilmesi Hakkında Yönetmelik. Erişim: URL: http://www.mevzuat.gov.tr/Metin.Aspx?MevzuatKod=7.5.4916&MevzuatIliski=0 (Erişim tarihi: 25 Ocak 2019).
• Hassali MA, Shafie AA, Awaisu A, Ibrahim MI, Ping CC, Jamshed S. Physicians’ views on generic medicines: A narrative review. J Generic Med 2010;7:30-9.
• Chua GN, Hassali MA, Shafie AA, Awaisu A. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia. Health Policy 2010;95:229-35.
• Dunne S, Shannon B, Dunne C, Cullen W. A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacol Toxicol 2013;14:1.
• Kersnik J, Peklar J. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies. J Clin Pharm Ther 2006;31:577-83.